Company / Free Cash Flow per Share
BioAge Labs, Inc. Free Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.30
FY2025
5-year range
-$22.43 / -$2.30
FY2023-FY2025
Trend
+52.5%
vs FY2024
Sector context
#138 of 192
Health Care
What the data says
At $-2.30, BioAge Labs, Inc.'s free cash flow per share ranks #138 of 192 in the Health Care sector. Improved from $-22.43 to $-2.30 over the past 2 years.
Based on SEC 10-K filings.
-2.30 in FY2025.
Improved from $-22.43 to $-2.30 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#138 of 192 in Health CareTop 72% of 192This company -$2.30 Sector average -$19.84
▼
+88.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 52.5% year-over-year.
- Ranks #138 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.30 | +52.5% |
| FY2024 | -$4.84 | +78.4% |
| FY2023 | -$22.43 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026